Silke Kinzel-Hausser
Goettingen, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Bruton Tyrosine Kinase Inhibition Limits Multiple Sclerosis Disease-Driving Inflammation While Promoting Regulatory B Cells.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: November 25, 2025
Trogocytosis challenges the cellular specificity of lineage markers and monoclonal antibodies.
Journal: Nature reviews. Immunology
Published: July 25, 2023
IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity.
Journal: Acta neuropathologica
Published: December 05, 2022
Proinflammatory CD20+ T cells contribute to CNS-directed autoimmunity.
Journal: Science translational medicine
Published: March 30, 2022
Proinflammatory CD20+ T Cells are Differentially Affected by Multiple Sclerosis Therapeutics.
Journal: Annals of neurology
Published: June 18, 2021
B cells reappear less mature and more activated after their anti-CD20-mediated depletion in multiple sclerosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 01, 2020
Differential Effects of MS Therapeutics on B Cells-Implications for Their Use and Failure in AQP4-Positive NMOSD Patients.
Journal: International journal of molecular sciences
Published: June 23, 2020
Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients.
Journal: Journal of neuroinflammation
Published: May 29, 2019
Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
Journal: Brain pathology (Zurich, Switzerland)
Published: December 06, 2018
The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.
Journal: Frontiers in immunology
Published: November 17, 2018
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 09, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026